Surgeon Simulator

Bossa Studios · 2013 · $9.99 · Action · deal grade A

• Estimated net residual revenue: $2.4k to $3.5k per month
• Opportunity: $6.2k per month at x2.10 dormancy
• Estimated lifetime owners: 1.0M
• 82%% positive across 16880 reviews · 54.8 reviews/month

Why it's flagged

• Developer silent for 6.9 years
• Studio active elsewhere (6 titles tracked), so this one may welcome a partner
• Last build shipped 10.3 years ago
• Last discounted 1 months ago, 10 sales in the last 12 months

Analyst notes (AI-assisted)

A physics-comedy surgical simulator where deliberately bad controls and absurdist humor drive the entertainment rather than simulation accuracy.

Surgeon Simulator remains quietly profitable at $2.9k/mo residual revenue on a $2.2M lifetime base, with 82% positive sentiment driven by its uniquely polarizing control scheme and meme appeal. The title's low review velocity (55/mo, 6-month avg) and 10 discounts in 12 months suggest moderate promotional dependency; however, the 1.1 elasticity and 18% key-share indicate healthy organic interest and minimal gray-market leakage. Best fit: publishing partners seeking catalog depth in the comedy/streamer-bait category, or a studio eyeing IP revival with VR or mobile ports already proven viable. Most realistic play: publishing.

• Risk: Core appeal is novelty and meme virality; sustained engagement requires periodic content drops or meta-humor refresh to avoid dormancy below $2.3k/mo.
• Risk: VR port praised in reviews but PC controls remain a friction point; platform modernization (engine, controller mapping) will be necessary if revival is pursued.
• Risk: Developer quiet for 83 months (last public post Q3 2016); no evidence of active stewardship, making post-acquisition support critical to retain community goodwill.

This case as Markdown · Estimates carry ±30-50%% error per title.